Balanced Portfolio Recommendation: Trim Sell Silver (ETPMAG)
Trim Sell Silver (ETPMAG) US Inflation numbers overnight were higher than expected. Silver does not do well in a higher interest rate environment, so time to trim the ETPMAG position
Balanced Portfolio
Balanced Portfolio Recommendation: Switch PDN to URNM ETF
Given these dynamics, transitioning from Paladin Energy to the Uranium ETF (URNM) is recommended for those seeking to maintain exposure to the uranium sector while managing risk more effectively. URNM offers a diversified investment in uranium and nuclear energy stocks, thereby reducing the volatility associated with individual stock performances like Paladin’s. This move aligns with a strategy to capitalize on the thematic growth of the uranium sector while mitigating risk through diversification.
Balanced Portfolio Recommendation: Switch RMD & TLX to DRUG ETF
Switch RMD & TLX to DRUG ETF
Balanced Portfolio Recommendation: Trim Take Profit – Elders (ELD)
For our trading strategy, we’re adjusting our position in Elders Limited (ELD) by reducing our allocation by 1% due to its recent impressive performance. Despite this adjustment, we will maintain a 2% allocation in ELD, recognizing the stock’s strong momentum. Additionally, the significant rainfall recently suggests the potential for continued positive performance, justifying our decision to retain a substantial investment in the company.
Balanced Portfolio Recommendation: Trim Take Profit – Graincorp (GNC)
GNC has gone parabolic. Time to trim – take profits on position. Reduce allocation by 1.5% down from 5.5% to 4%
Balanced Portfolio Recommendation: Buy Worley Limited (WOR)
Adding WOR to Balanced Portfolio with a 3% allocation. WOR is a global company headquartered in Australia is a global provider of professional project and asset services in the energy, chemicals and resources sectors. As a knowledge-based service provider, they use their knowledge and capabilities to support the customers to reduce their emissions and move towards a low carbon future.
Balanced Portfolio Recommendation: Buy 1.5% Liontown Resources Ltd (LTR) & Buy 2% Mineral Resources Ltd MIN
It’s been a rocky ride for Lithium so far this year but through all the noise, we see quality buying opportunities in the space for the long term. Mining giants Gina Rinehart and Chris Ellison have long track records in running profitable mining operations in literally the most abundant mineral on the planet, Iron Ore and they are aggressively buying into the next mining boom of Lithium.
Alpha Portfolio Recommendation: Relative Value Play – SELL GEAR & BBUS
given the recent strength in Tech stocks in the US and the failure of the ASX200 at record high of 7630 for the 4th time in 3 years
Balanced Portfolio Recommendation: Buy Treasury Wine Estate (TWE)
The recent positive speculation about the removal of trade tariffs from China this quarter was squashed by a massive cap raise of $825m at 10.80 per share to fund the acquisition of high-end Californian wine group Daou Vineyards in a deal worth up to $US1 billion ($1.6 billion) as it steps up expansion in the United States luxury wine market.
Balanced Portfolio Recommendation: Buy Incitec Pivot (IPL)
Incitec Pivot Limited (IPL) is a manufacturer and distributor of industrial explosives, industrial chemicals and fertilisers to the agriculture and mining industries.
Balanced Portfolio Recommendation: Buy Stanmore Resources (SMR)
Stanmore Resources (SMR) owns and operates the Isaac Plains Complex in Queensland’s prime Bowen Basin region which includes the Isaac Plains Mine and processing facilities, the adjoining Isaac Plains East (operational), Isaac Downs Project (under development) and the Isaac Plains Underground Project.
Balanced Portfolio Recommendation: Switch 2% ResMed (RMD) to Clinuvel Pharmaceuticals Ltd (CUV)
With the recent run in RMD we are looking to bank some profits here at $29 (+20%) while we see further upside in the stock, the risk that further developments in the GLP-1 space could derail this recent run. Particularly a study due from Eli Lily a maker of Zepbound in the next month.
We still prefer exposure in the healthcare space and are recommending a switch of our RMD allocation to Clinuvel (CUV) a skin disease treatment for sufferers of EPP. They are also in Phase 2 of a stroke treatment drug which is looking promising